News Releases Year: All News201920182017201620152014201320122011 Items per page All News2550 November 1, 2017 Summary ToggleAllena Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering Read more July 27, 2017 Summary ToggleEuropean Commission Grants Orphan Drug Designation to Allena Pharmaceuticals’ Investigational Therapy for the Treatment of Primary Hyperoxaluria Read more July 13, 2017 Summary ToggleFDA Grants Orphan Drug Designation to Allena Pharmaceuticals’ Investigational Therapy for the Treatment of Primary Hyperoxaluria Read more May 31, 2017 Summary ToggleAllena Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference Read more March 3, 2017 Summary ToggleAllena Pharmaceuticals to Present at the Cowen and Company 37th Annual Health Care Conference Read more January 5, 2017 Summary ToggleAllena Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference Read more October 4, 2016 Summary ToggleAllena Pharmaceuticals and Health Advances Present Analysis of Recurrent Kidney Stone Disease at the Academy of Managed Care Pharmacy Nexus Conference Read more September 7, 2016 Summary ToggleAllena Pharmaceuticals Strengthens Leadership Team, Names Edward Wholihan as Chief Financial Officer and Robert Alexander, PhD, to Board of Directors Read more June 2, 2016 Summary ToggleAllena Pharmaceuticals to Present at the 2016 Jefferies Healthcare Conference Read more May 5, 2016 Summary ToggleFDA Grants Orphan Drug Designation to Allena’s Investigational Therapy for the Treatment of Pediatric Hyperoxaluria Read more Pagination First page First Previous page Previous … Page 3 Current page 4 Page 5 Page 6 Next page Next Last page Last
